Platelet Function in Patients with Diabetes Mellitus: From a Theoretical to a Practical Perspective
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Platelet Function in Patients with Diabetes Mellitus: From a Theoretical to a Practical Perspective
Authors
Keywords
-
Journal
International Journal of Endocrinology
Volume 2011, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2011-08-22
DOI
10.1155/2011/742719
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relation of Aspirin Failure to Clinical Outcome and to Platelet Response to Aspirin in Patients With Acute Myocardial Infarction
- (2011) Roy Beigel et al. AMERICAN JOURNAL OF CARDIOLOGY
- Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial
- (2011) K. W. Park et al. HEART
- Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention
- (2011) Matthew J. Price JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multicenter Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications After Drug-Eluting Stent Implantation for Coronary Heart Disease
- (2011) Jung-Won Suh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Aspirin Responsiveness and Platelet Reactivity on Early Vein Graft Thrombosis After Coronary Artery Bypass Graft Surgery
- (2011) Tyler J. Gluckman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel
- (2011) Fabio Mangiacapra et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry)
- (2010) Seung-Whan Lee et al. AMERICAN HEART JOURNAL
- Comparison of Platelet Reactivity and Periprocedural Outcomes in Patients With Versus Without Diabetes Mellitus and Treated With Clopidogrel and Percutaneous Coronary Intervention
- (2010) Fabio Mangiacapra et al. AMERICAN JOURNAL OF CARDIOLOGY
- Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) trial
- (2010) Michael G. Hennerici et al. CARDIOVASCULAR DRUGS AND THERAPY
- Clinical Predictors of High Posttreatment Platelet Reactivity to Clopidogrel in Koreans
- (2010) Kyung Woo Park et al. Cardiovascular Therapeutics
- Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes
- (2010) Michael Pignone et al. CIRCULATION
- Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies
- (2010) Paul A. Gurbel et al. CIRCULATION
- Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease
- (2010) S. Goto et al. EUROPEAN HEART JOURNAL
- Diabetics with acute coronary syndrome: advances, challenges, and uncertainties
- (2010) P. W. Radke et al. EUROPEAN HEART JOURNAL
- Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2010) Stefan James et al. EUROPEAN HEART JOURNAL
- Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation
- (2010) Nicoline J. Breet JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High on-aspirin platelet reactivity as measured with aggregation-based, cyclooxygenase-1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events
- (2010) N. J. BREET et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis
- (2010) Jessica L Mega et al. LANCET
- Aspirin for primary prevention of cardiovascular disease in diabetes mellitus
- (2010) Michael Pignone et al. Nature Reviews Endocrinology
- Sulfonylureas and on-clopidogrel platelet reactivity in type 2 diabetes mellitus patients
- (2010) Ankie M. Harmsze et al. PLATELETS
- Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: The Early Rapid ReversAl of Platelet ThromboSis with Intravenous Elinogrel before PCI to Optimize REperfusion in Acute Myocardial Infarction (ERASE MI) pilot trial
- (2009) Jeffrey S. Berger et al. AMERICAN HEART JOURNAL
- Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50 trial
- (2009) David A. Morrow et al. AMERICAN HEART JOURNAL
- Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [CHARISMA] Trial)
- (2009) Arijit Dasgupta et al. AMERICAN JOURNAL OF CARDIOLOGY
- Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux
- (2009) Anna C. Calkin et al. CIRCULATION
- 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)
- (2009) Frederick G. Kushner et al. CIRCULATION
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
- (2009) Paul A. Gurbel et al. CIRCULATION
- Factors Contributing to Increased Platelet Reactivity in People With Diabetes
- (2009) D. J. Schneider DIABETES CARE
- Global estimates of the prevalence of diabetes for 2010 and 2030
- (2009) J.E. Shaw et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Randomized Comparison of Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With High Post-Treatment Platelet Reactivity
- (2009) Young-Hoon Jeong et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Insulin/IGF-1 hybrid receptor expression on human platelets: consequences for the effect of insulin on platelet function
- (2009) R.W. HUNTER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness of Clopidogrel plus Aspirin versus Aspirin Alone for Secondary Prevention of Cardiovascular Events: Results from the CHARISMA Trial
- (2009) Jersey Chen et al. VALUE IN HEALTH
- Oxidative Stress and Platelets
- (2008) Jane E. Freedman ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Infliximab treatment shifts the balance between stimulatory and inhibitory Fcγ receptor type II isoforms on neutrophils in patients with rheumatoid arthritis
- (2008) Kristina Belostocki et al. ARTHRITIS AND RHEUMATISM
- Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies
- (2008) G. Spinetti et al. CARDIOVASCULAR RESEARCH
- Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
- (2008) Stephen D. Wiviott et al. CIRCULATION
- Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome
- (2008) A. Undas et al. DIABETES CARE
- A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study
- (2008) D. J. Angiolillo et al. EUROPEAN HEART JOURNAL
- Basic and Translational Research on Proteinase-Activated Receptors: Antagonism of the Proteinase-Activated Receptor 1 for Thrombin, a Novel Approach to Antiplatelet Therapy for Atherothrombotic Disease
- (2008) Madhu Chintala et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Role of Reticulated Platelets and Platelet Size Heterogeneity on Platelet Activity After Dual Antiplatelet Therapy With Aspirin and Clopidogrel in Patients With Stable Coronary Artery Disease
- (2008) Sasidhar Guthikonda et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Elevated Plasma Fibrinogen and Diabetes Mellitus Are Associated With Lower Inhibition of Platelet Reactivity With Clopidogrel
- (2008) Lawrence Ang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of the PFA-100™ closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis
- (2008) J.-L. RENY et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search